<DOC>
	<DOCNO>NCT02185209</DOCNO>
	<brief_summary>The purpose study investigate use systemic adjunctive antibiotic treatment periimplantitis need .</brief_summary>
	<brief_title>Surgical Treatment Peri-implantitis With Without Systemically Adjunctive Antibiotics</brief_title>
	<detailed_description>This study give opportunity draw scientifically base conclusion recommendation use adjunctive systemic antibiotic treatment peri-implantitis . This study also able determine ecological impact oropharyngeal intestinal microflora different antibiotic treatment . The lack knowledge area highlight Food Drug Administration The Swedish Council Health Technology Assessment ( SBU )</detailed_description>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Peri-Implantitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Penicillin V</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>1 . Male female ≥1865 year 2 . Patients refer general dentist specialist clinic periodontology treatment periimplantitis . 3 . Having sign periimplantitis around least one osseointegrated dental implant function ≥ one year 4 . Periimplantitis diagnose ; PPD ≥ 6mm found dental implant association BOP and/or suppuration together loss marginal alveolar bone 2 mm detect intraoral radiograph ( give radiographic exposure least ≥ 3 fixture thread ) . 5 . Partially completely edentulous subject healthy treat periodontal condition enrol regular supportive program . 6 . FullMouth Plaque Score ( FMPS ) ≤ 25 7 . Signed informed consent 1 . Known allergy amoxicillin , penicillin ( PcV ) , metronidazole betalactamic 2 . Contraindication dental surgical treatment ( i.e . immunocompromised , uncontrolled DM ( BGHbA1C 89 % , 6475 mmol/mol ) , osteoporosis , I.V bisphosphonate treatment due malignancy , pregnant lactate woman ) . 3 . Incapability perform basal oral hygiene measure due physical mental disorder . 4 . Received systemic antimicrobial therapy past three month . 5 . Currently allopurinol , digoxin , disulfiram , lithium , busulfan , 5fluorouracil , methotrexate , phenytoin , cyclosporine warfarin . 6 . Known severe chronic peripheral central disease nervous system 7 . Known alcohol abuse 8 . Known hepatic encephalopathy 9 . Known lactose intolerance , galactose intolerance 10 . Untreated periodontal condition . 11 . Implant show sign mobility . 12 . Implants bone loss exceed 2/3 length implant implant bone loss beyond transverse opening hollow implant . 13 . Any medical condition concomitant medication , opinion investigator , might interfere evaluation study objective jeopardize patient safety Patients xerostomia slow bowel motion exclude group patient provide salivary fecal sample .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>